– USA, MN – Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company today announced the appointments of Cynthia Burks and Dr. Charisse Sparks (M.D.) to its Board as Independent Directors, effective July 28, 2022, bringing the Board to 11 members of whom 10 are independent.
“The Inspire team is thrilled to add these two very talented individuals to our Board. Cynthia’s extensive experience in all critical aspects of human resources will be invaluable as our organization continues to grow. Further, Charisse’s broad medical device industry expertise further strengthens our Board as we continue to enhance the Inspire therapy platform with a focus on delivering strong and consistent patient outcomes,” said CEO, Tim Herbert.
About Cynthia Burks
Cynthia Burks is the former CHRO for Genentech, Inc., a member of the Roche Group. In this role, Ms. Burks led the company’s efforts to attract, develop and retain employees at Genentech, which has over 13,500 employees. An innovative leader, she brings strong analytical skills, and expertise in all areas of human capital strategy, including talent management, culture, diversity, equity, inclusion, and organizational design. Ms. Burks is an observer on the board of directors of the publicly traded WD-40 Company and a director on the board of directors of Torch, a privately held company offering integrated coaching, mentoring and learning software, as well as serving on two non-profit organizations, Juma Ventures, and Summer Search.
About Dr. Charisse Y. Sparks
Dr. Charisse Sparks is CMO of AppliedVR, Inc., a privately-held company pioneering virtual reality-based treatments that address the complexity of pain and other conditions, where she is responsible for leading the company’s medical, clinical, regulatory, and quality affairs functions. Previously, Dr. Sparks was VP of DePuy Synthes, the Orthopaedics Company of Johnson and Johnson. While at DePuy Synthes, she was an integral leader in Johnson & Johnson’s “Our Race to Health Equity,” an initiative that aims to eradicate racial and social injustice as a public health threat by seeking to eliminate health inequities for people of color. Dr. Sparks has experience in R&D, Regulatory Affairs, Quality, Commercial, and Health Economics & Market Access. She has led evidence-generation strategies for global market access to orthopedic and craniomaxillofacial (CMF) products. As an orthopedic surgeon, she was the third Black female, fellowship-trained Orthopaedic Trauma Surgeon in the country, completing her training at Harvard Medical School.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For more information: https://www.inspiresleep.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.